These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21533098)

  • 1. Classical Mus musculus Igκ enhancers support transcription but not high level somatic hypermutation from a V-lambda promoter in chicken DT40 cells.
    Kothapalli NR; Norton DD; Fugmann SD
    PLoS One; 2011 Apr; 6(4):e18955. PubMed ID: 21533098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation.
    Inlay MA; Gao HH; Odegard VH; Lin T; Schatz DG; Xu Y
    J Immunol; 2006 Jul; 177(2):1146-51. PubMed ID: 16818772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
    Yang SY; Fugmann SD; Schatz DG
    J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
    Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
    PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of core DNA elements that target somatic hypermutation.
    Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
    J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences.
    Tarsalainen A; Maman Y; Meng FL; Kyläniemi MK; Soikkeli A; Budzyńska P; McDonald JJ; Šenigl F; Alt FW; Schatz DG; Alinikula J
    J Immunol; 2022 Jan; 208(1):143-154. PubMed ID: 34862258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation.
    Xiang Y; Garrard WT
    J Immunol; 2008 May; 180(10):6725-32. PubMed ID: 18453592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
    McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
    J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID-mediated diversification within the IgL locus of chicken DT40 cells is restricted to the transcribed IgL gene.
    Gopal AR; Fugmann SD
    Mol Immunol; 2008 Apr; 45(7):2062-8. PubMed ID: 18023479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes.
    Gorman JR; van der Stoep N; Monroe R; Cogne M; Davidson L; Alt FW
    Immunity; 1996 Sep; 5(3):241-52. PubMed ID: 8808679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.
    Hengstschläger M; Williams M; Maizels N
    Eur J Immunol; 1994 Jul; 24(7):1649-56. PubMed ID: 8026525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attracting AID to targets of somatic hypermutation.
    Tanaka A; Shen HM; Ratnam S; Kodgire P; Storb U
    J Exp Med; 2010 Feb; 207(2):405-15. PubMed ID: 20100870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recruitment of activation induced cytidine deaminase to the immunoglobulin locus by a regulatory element.
    Kim Y; Tian M
    Mol Immunol; 2010 May; 47(9):1860-5. PubMed ID: 20334924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: a cis-acting DNA element targets AID-mediated sequence diversification to the chicken Ig light chain gene locus.
    Kothapalli N; Norton DD; Fugmann SD
    J Immunol; 2008 Feb; 180(4):2019-23. PubMed ID: 18250404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of mutational and transcriptional enhancers in Ig genes.
    Kothapalli NR; Collura KM; Norton DD; Fugmann SD
    J Immunol; 2011 Sep; 187(6):3247-55. PubMed ID: 21844395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in RNA polymerase II progression influence somatic hypermutation of Ig-related genes by AID.
    Kodgire P; Mukkawar P; Ratnam S; Martin TE; Storb U
    J Exp Med; 2013 Jul; 210(7):1481-92. PubMed ID: 23752228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
    Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor NF-kappa B regulates Ig lambda light chain gene rearrangement.
    Bendall HH; Sikes ML; Oltz EM
    J Immunol; 2001 Jul; 167(1):264-9. PubMed ID: 11418658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.